UN health agency issues alert on falsified medicines used for diabetes treatment, weight loss
The spurious semaglutides – of a specific brand Ozempic – were found in Brazil, the United Kingdom in October 2023, and the United States in December 2023, and were delivered through a regular supply chain. The WHO’s official notice follows reports of “falsified semaglutide products” across all geographical regions from its Global Surveillance and Monitoring […]
Continue Reading